Sell in May and Go Away—Starting With These 3 Stocks

Why It Matters

Trimming these under‑performing positions helps investors avoid downside risk and redirects capital toward higher‑yield, cash‑flow‑stable assets, a crucial move as AI spending escalates and consumer spending tightens.

Key Takeaways

• DexCom faces Abbott competition and FDA warning, slowing growth.
• Colgate‑Palmolive shows flat earnings, low‑margin categories limit upside.
• Oracle's $250 bn lease commitments create a massive cash‑flow gap.
• Sell‑in‑May rule guides trimming stocks with weakening risk/reward.
• Utilities and healthcare REITs offer stronger yields and cash‑flow visibility.

Pulse Analysis

The “sell in May and go away” adage is more than folklore; data from the S&P 500 since 1945 shows an average 5‑percentage‑point performance gap between the first and second half of the year. Asset managers use this seasonality to rotate out weaker holdings and capture higher‑return opportunities during the summer lull. Lichtenfeld’s approach mirrors that discipline, targeting stocks where valuation, momentum and balance‑sheet health diverge, thereby protecting portfolios from sector‑specific headwinds.

DexCom, a leader in continuous glucose monitoring, now confronts intensified rivalry from Abbott’s FreeStyle Libre and an FDA warning letter that dampens investor confidence. Meanwhile, Colgate‑Palmolive, despite its iconic brand, is stuck with flat earnings and low‑margin product lines that erode its defensive appeal amid price‑sensitive consumer behavior. Oracle, riding the AI hype, has pledged roughly $250 billion in lease obligations for data‑center expansion, creating a projected cash‑flow shortfall that dwarfs the buffers enjoyed by larger cloud rivals. These dynamics illustrate how sector‑specific pressures can outweigh broader market strength.

For investors seeking resilience, the article points to alternatives with more predictable cash flows, such as utilities with data‑center exposure and healthcare REITs that combine steady dividends with sector growth. Larger AI players like Microsoft and Alphabet also possess deep cash reserves to weather spending volatility. By pruning stocks with deteriorating risk‑reward profiles and reallocating to income‑generating, cash‑flow‑rich assets, investors can align with both seasonal trends and the evolving AI investment landscape.